BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23510015)

  • 21. HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.
    Cao M; Gao J; Zhou H; Huang J; You A; Guo Z; Fang F; Zhang W; Song T; Zhang T
    Tumour Biol; 2016 Feb; 37(2):1651-62. PubMed ID: 26307391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.
    Emerling BM; Benes CH; Poulogiannis G; Bell EL; Courtney K; Liu H; Choo-Wing R; Bellinger G; Tsukazawa KS; Brown V; Signoretti S; Soltoff SP; Cantley LC
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3483-8. PubMed ID: 23378636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells.
    Sakuma Y; Matsukuma S; Nakamura Y; Yoshihara M; Koizume S; Sekiguchi H; Saito H; Nakayama H; Kameda Y; Yokose T; Oguni S; Niki T; Miyagi Y
    Lab Invest; 2013 Oct; 93(10):1137-46. PubMed ID: 23938604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.
    Harrington BS; He Y; Davies CM; Wallace SJ; Adams MN; Beaven EA; Roche DK; Kennedy C; Chetty NP; Crandon AJ; Flatley C; Oliveira NB; Shannon CM; deFazio A; Tinker AV; Gilks CB; Gabrielli B; Brennan DJ; Coward JI; Armes JE; Perrin LC; Hooper JD
    Br J Cancer; 2016 Feb; 114(4):417-26. PubMed ID: 26882065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Trask protein interactions in brain metastatic cohorts of lung cancers.
    Wu H; Shang LQ; Chen RL; Yang SM; Wang SL; Wang J; Sun G
    Tumour Biol; 2015 Jun; 36(6):4181-7. PubMed ID: 25775948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CUB domain-containing protein 1 (CDCP1) binds transforming growth factor beta family members and increase TGF-β1 signaling pathway.
    Predes D; Cruz JVR; Abreu JG; Mendes FA
    Exp Cell Res; 2019 Oct; 383(1):111499. PubMed ID: 31302030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.
    Wortmann A; He Y; Christensen ME; Linn M; Lumley JW; Pollock PM; Waterhouse NJ; Hooper JD
    J Biol Chem; 2011 Dec; 286(49):42303-42315. PubMed ID: 21994943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
    Seidel J; Kunc K; Possinger K; Jehn C; Lüftner D
    Biochem Biophys Res Commun; 2011 Oct; 414(1):226-32. PubMed ID: 21945930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.
    Gandji LY; Proust R; Larue L; Gesbert F
    PLoS One; 2015; 10(4):e0123472. PubMed ID: 25876044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
    He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
    Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
    Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
    Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers.
    Nelson LJ; Wright HJ; Dinh NB; Nguyen KD; Razorenova OV; Heinemann FS
    Am J Pathol; 2020 Feb; 190(2):484-502. PubMed ID: 31843498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of HIF-2α on regulating CDCP1 to promote hepatocellular carcinoma metastasis].
    Cao MQ; Gao JR; Huang JF; You AB; Guo ZG; Zhou HY; Fang F; Zhang W; Zhu XL; Zhang T
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):18-23. PubMed ID: 28104028
    [No Abstract]   [Full Text] [Related]  

  • 37. CDCP1 identifies a CD146 negative subset of marrow fibroblasts involved with cytokine production.
    Iwata M; Torok-Storb B; Wayner EA; Carter WG
    PLoS One; 2014; 9(10):e109304. PubMed ID: 25275584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of tumor metastasis: functional immune modulation of the CUB domain containing protein 1.
    Fukuchi K; Steiniger SC; Deryugina E; Liu Y; Lowery CA; Gloeckner C; Zhou B; Kaufmann GF; Quigley JP; Janda KD
    Mol Pharm; 2010 Feb; 7(1):245-53. PubMed ID: 19916495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
    Kollmorgen G; Niederfellner G; Lifke A; Spohn GJ; Rieder N; Harring SV; Bauss F; Burtscher H; Lammers R; Bossenmaier B
    Mol Oncol; 2013 Dec; 7(6):1142-51. PubMed ID: 24055141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.
    Law ME; Ferreira RB; Davis BJ; Higgins PJ; Kim JS; Castellano RK; Chen S; Luesch H; Law BK
    Breast Cancer Res; 2016 Aug; 18(1):80. PubMed ID: 27495374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.